Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2007-3-26
pubmed:abstractText
This article examines the association between the organizational characteristics of drug abuse treatment programs for offenders and the provision of wraparound services and three types of treatment orientations. Data are from the National Criminal Justice Treatment Practices Survey, which was conducted with program directors (N = 217). A greater number of wraparound services provided were associated with inpatient treatment, specialized treatment facilities, community setting (vs. correctional), services provided for more types of client populations, college-educated staff, and planned treatment for > 180 days. Therapeutic community orientation was associated with prison-based treatment and specialized treatment facilities. Cognitive-behavioral therapy orientation was associated with higher perceived importance of community treatment, more perceived staff influence on treatment, and treatment for 91-180 days. The 12-step orientation was most strongly associated with having staff specialized in substance abuse. Study findings have implications for developing effective reentry programs for offenders that bridge correctional and community treatment.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-10069143, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-10349603, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-10419225, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-10467763, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-10636604, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-10665073, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-10857471, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-10993386, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-11138707, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-11138708, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-11242322, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-11516921, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-11932131, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-12072164, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-12072165, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-12090408, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-12127469, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-12487238, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-12492259, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-12495792, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-12834661, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-14629989, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-14698799, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-14986881, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-15050084, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-15223088, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-15450644, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-15540491, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-15583113, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-15602141, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-15925269, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-16289523, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-16292114, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-16320106, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-16616161, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-7655312, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-7655313, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-8699546, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-8712185, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-9494948, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-9650138, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-9673073, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-9840784, http://linkedlifedata.com/resource/pubmed/commentcorrection/17383553-9888124
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0740-5472
pubmed:author
pubmed:issnType
Print
pubmed:volume
32
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
291-300
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Organizational characteristics of drug abuse treatment programs for offenders.
pubmed:affiliation
UCLA Integrated Substance Abuse Programs, NPI-Semel Institute for Neuroscience, David Geffen School of Medicine at UCLA, University of California, Los Angeles, CA 90025, USA. grella@ucla.edu
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural